Trial intelligence / Profile preview

Vitamin C to Improve Tissue Healing by Administration of Multiple Intravenous Dosages

2014-005612-41Phase 4Active

Sponsor
Meander Medical Center
Start
Nov 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of ascorbic acid in Abnormal wound healing, Skin and connective tissue disease and arteriosclerosis obliterans, sponsored by Meander Medical Center. Primary endpoint: Primary surgical wound area reduction. Started Nov 2015; status: active.

02

Drugs

ascorbic acid
03

Conditions

Abnormal wound healingSkin and connective tissue diseasearteriosclerosis obliterans

Beyond the preview

Go deeper on 2014-005612-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-005612-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call